Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment

Authors

  • Maysaa Abdulla Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden
  • Peter Hollander Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden
  • Cecilia Lindskog Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden
  • Christer Sundström Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden
  • Gunilla Enblad Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
  • Leonie Saft Department of Oncology and Pathology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
  • Rose-Marie Amini Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden

DOI:

https://doi.org/10.1080/0284186X.2022.2075239

Abstract

No abstracts available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2022-07-03

How to Cite

Abdulla, M., Hollander, P., Lindskog, C., Sundström, C., Enblad, G., Saft, L., & Amini, R.-M. (2022). Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment. Acta Oncologica, 61(7), 824–829. https://doi.org/10.1080/0284186X.2022.2075239

Issue

Vol. 61 No. 7 (2022): Acta Oncologica

Section

Articles